August 19, 2025 - 05:25

Kohl’s has officially appointed Steven Dee as the company’s new chief technology officer, effective August 25. In this pivotal role, Dee will oversee the technology and information platforms that are essential for supporting Kohl’s omnichannel business model. His leadership is expected to play a crucial role in enhancing the company’s technological infrastructure, which is vital for executing its broader business strategies.
Dee brings a wealth of experience to the position, having previously worked in various leadership roles within the technology sector. His expertise in integrating technology with business operations will be instrumental in driving innovation at Kohl’s. The company aims to leverage Dee's insights to improve customer experiences and streamline operations across all channels.
As the retail landscape continues to evolve, Kohl’s commitment to enhancing its technology capabilities under Dee's guidance signals a strategic move to stay competitive and meet the changing needs of consumers. The appointment reflects the company's dedication to embracing digital transformation in the retail industry.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...